518 related articles for article (PubMed ID: 21541274)
21. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
[TBL] [Abstract][Full Text] [Related]
22. GPR143 Gene Mutations in Five Chinese Families with X-linked Congenital Nystagmus.
Han R; Wang X; Wang D; Wang L; Yuan Z; Ying M; Li N
Sci Rep; 2015 Jul; 5():12031. PubMed ID: 26160353
[TBL] [Abstract][Full Text] [Related]
23. [Oculocutaneous and ocular albinism].
Kubasch AS; Meurer M
Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.
Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P
Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966
[TBL] [Abstract][Full Text] [Related]
25. GPR143 mutations in Chinese patients with ocular albinism type 1.
Jia X; Yuan J; Jia X; Ling S; Li S; Guo X
Mol Med Rep; 2017 May; 15(5):3069-3075. PubMed ID: 28339057
[TBL] [Abstract][Full Text] [Related]
26. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
[TBL] [Abstract][Full Text] [Related]
27. Inheritance of a novel mutated allele of the OCA2 gene associated with high incidence of oculocutaneous albinism in a Polynesian community.
Johanson HC; Chen W; Wicking C; Sturm RA
J Hum Genet; 2010 Feb; 55(2):103-11. PubMed ID: 20019752
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the iris thickness changes for the Chinese families with GPR143 gene mutations.
Jiang J; Yang L; Li H; Huang L; Li N
Exp Eye Res; 2019 Dec; 189():107819. PubMed ID: 31574285
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.
Jaworek TJ; Kausar T; Bell SM; Tariq N; Maqsood MI; Sohail A; Ali M; Iqbal F; Rasool S; Riazuddin S; Shaikh RS; Ahmed ZM
Orphanet J Rare Dis; 2012 Jun; 7():44. PubMed ID: 22734612
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.
Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K
Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782
[TBL] [Abstract][Full Text] [Related]
31.
Xu J; Zheng Y; Cheng L; Sun H; Yu X; Gu F; Song E
Mol Vis; 2023; 29():234-244. PubMed ID: 38222445
[TBL] [Abstract][Full Text] [Related]
32. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.
Kerr R; Stevens G; Manga P; Salm S; John P; Haw T; Ramsay M
Hum Mutat; 2000; 15(2):166-72. PubMed ID: 10649493
[TBL] [Abstract][Full Text] [Related]
33. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism.
Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C
Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807
[TBL] [Abstract][Full Text] [Related]
34. Oculocutaneous albinism (OCA) in Colombia: first molecular screening of the TYR and OCA2 genes in South America.
Urtatiz O; Sanabria D; Lattig MC
J Dermatol Sci; 2014 Dec; 76(3):260-2. PubMed ID: 25455140
[No Abstract] [Full Text] [Related]
35. A novel GPR143 mutation in a Chinese family with X‑linked ocular albinism type 1.
Gao X; Liu T; Cheng X; Dai A; Liu W; Li R; Zhang M
Mol Med Rep; 2020 Jan; 21(1):240-248. PubMed ID: 31746431
[TBL] [Abstract][Full Text] [Related]
36. Unveiling genetics of non-syndromic albinism using whole exome sequencing: A comprehensive study of TYR, TYRP1, OCA2 and MC1R genes in 17 families.
Zaman Q; Khan J; Ahmad M; Khan H; Chaudhary HT; Rehman G; Rahman OU; Shah MM; Hussain J; Jamal Q; Khan BT; Khan MA; Sadeeda ; Sahar K; Idrees M; Ahmad R; Faisal MS; Khan MI; Khisroon M; Abdulkareem AA; Lee E; Ryu SW; Bibi N; Muthaffar OY; Jelani M; Naseer MI
Gene; 2024 Feb; 894():147986. PubMed ID: 37956964
[TBL] [Abstract][Full Text] [Related]
37. MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2).
King RA; Willaert RK; Schmidt RM; Pietsch J; Savage S; Brott MJ; Fryer JP; Summers CG; Oetting WS
Am J Hum Genet; 2003 Sep; 73(3):638-45. PubMed ID: 12876664
[TBL] [Abstract][Full Text] [Related]
38. Oculocutaneous albinism type 1A: a case report.
Karaman A
Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
[TBL] [Abstract][Full Text] [Related]
39. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.
Simeonov DR; Wang X; Wang C; Sergeev Y; Dolinska M; Bower M; Fischer R; Winer D; Dubrovsky G; Balog JZ; Huizing M; Hart R; Zein WM; Gahl WA; Brooks BP; Adams DR
Hum Mutat; 2013 Jun; 34(6):827-35. PubMed ID: 23504663
[TBL] [Abstract][Full Text] [Related]
40. Delineating Novel and Known Pathogenic Variants in
Shakil M; Akbar A; Aisha NM; Hussain I; Ullah MI; Atif M; Kaul H; Amar A; Latif MZ; Qureshi MA; Mahmood S
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
